About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Ind-Swift Laboratories Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
532305
ISIN Demat
INE915B01019
Book Value
171.13
NSE Code
INDSWFTLAB
Dividend Yield %
0.00
Market Cap
8295.00
P/E
3.59
EPS
28.32
Face Value
10
BSE
NSE
04-Sep-2025
BSE
NSE
NSE F & O
04-Sep-2025
BSE
NSE
NSE F & O
Last Price
101.64
Net Change
-0.79
% Change
-0.77%
Prev.Close
102.43
Open
100.01
High
104.20
Low
100.01
Volume
5098
Last Price
102.14
Net Change
-0.43
% Change
-0.42%
Prev.Close
102.57
Open
103.00
High
104.00
Low
102.00
Volume
40802
Value
523302
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
104.20
52-Week High
158.00
52-Week Low
67.15
Value
4199518.89
Best Buy
0.00
Best Sell
102.14
Best Quantity
0
Sell Quantity
353
Today's Range
104.00
52-Week High
158.45
52-Week Low
68.72
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
353
Price
102.14
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
25-Sep-24
30-Sep-24
Dividend
10 %
22-Sep-11
Company News
25-07-2025
Ind-Swift Laboratories i...
04-07-2025
Ind-Swift Laboratories in...
21-06-2025
Ind-Swift Laboratories in...
22-01-2025
Ind-Swift Laboratories in...
04-01-2025
IND-Swift Laboratories in...
02-01-2025
Ind-Swift Laboratories pu...
10-12-2024
Ind-Swift Laboratories ac...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.